Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
  1. Home
  2. Publications
  3. Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway

Supplementary Figure S3 from Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway

Authors:
  • QLQiaoying Lv
    Qiaoying Lv
  • TSTong Su
    Tong Su
  • WLWei Liu
    Wei Liu
  • LWLulu Wang
    Lulu Wang
  • JHJiali Hu
    Jiali Hu
  • YCYali Cheng
    Yali Cheng
  • CNChengcheng Ning
    Chengcheng Ning
  • WSWeiwei Shan
    Weiwei Shan
  • XLXuezhen Luo
    Xuezhen Luo
  • XCXiaojun Chen
    Xiaojun Chen

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32701520
Abstract
Supplementary Figure S3. ApoA1 exerts its antitumor activity in a CD8 +T cell–dependent manner (related to Figure 3)
Keywords
  • GYNECOLOGICAL CANCERS
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • TUMOR MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.